		Technical Data
C7849-09C	COMP (Cartilage Oligomeric Matrix Protein, Cartilage Oligomeric Matrix Protein Precursor, EDM1, EPD1, Epiphyseal Dysplasia 1, Epiphyseal Dysplasia 1 Multiple, MED, MGC13181, MGC149768, PSACH, Pseudoachondroplasia, THBS5, Thrombospondin 5)

Description:
Applications:
Suitable for use in ELISA, Western Blotting. Other applications not tested.

Recommended Dilution:
Western Blotting: 1:1000-1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Type	Isotype	Clone	Grade
Pab	IgY		Serum

Size		Storage	Shipping	Source	Host
20ul		-20°C	Blue Ice	Rat	Chicken

Concentration:

~1mg/ml

Immunogen:

Recombinant rat COMP (Fragment T3+TC)

Purity:

Serum

Form

Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute in ddH2O.

Specificity:

Recognizes rat Cartilage Oligomeric Matrix Protein (COMP). Species Crossreactivity: Human, mouse.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

1. Spitznagel L, Nitsche DP, Paulsson M, Maurer P, Zaucke F. Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). Biochem J. 2004 Jan 15; 377(Pt 2): 479-87.